<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/04/Teladoc.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/04/Teladoc.png"/></p>
<p>Teladoc 的股价因疫情后对其服务的需求减弱而暴跌至历史低点，跌至 5.74 美元，较历史最高点 308 美元大幅下跌，市值从 460 亿美元降至目前的 10 亿美元。这一崩盘可能会继续，因为该股形成了看跌的头肩顶形态。</p>
<h2>Teladoc 的快速下滑，远程医疗行业的最大参与者</h2>
<p>Teladoc，远程医疗行业的最大参与者，从最受欢迎的公司变成了堕落的天使。</p>
<p>这种放缓发生在更多患者转向实体医院，导致其业务显著放缓。</p>
<p>最近的财报显示，其第三季度收入下降了 2%，降至 8.62 亿美元。即使在医疗行业持续增长的情况下，这一放缓依然发生。</p>
<p>其盈利能力也持续下降，调整后的 EBITDA 从 2024 年第三季度的 8330 万美元降至 6990 万美元。</p>
<p>Teladoc 的综合护理部门收入从 2024 年第三季度的 3.84 亿美元上升至 2025 年第三季度的 3.90 亿美元。然而，BetterHelp 部门持续恶化，其销售额从 2024 年同期的 2.57 亿美元降至 2.37 亿美元。</p>
<p>综合护理部门的 EBITDA 从 6800 万美元降至 6600 万美元，而 BetterHelp 仅赚取了 400 万美元。</p>
<p>这些数字的变化与其两个部门用户数量的分化有关。综合护理用户增加至 1.025 亿，而 BetterHelp 用户减少至 38.2 万。</p>
<p>华尔街分析师预计 Teladoc 的业务将继续承压。平均预估其第四季度收入为 6.35 亿美元，同比下降 0.81%。如果这一情况发生，其年收入将为 25 亿美元，同比下降 1.8%。</p>
<p>Teladoc 的亏损预计将持续，2025 年的每股年亏损将从今年的 86 美分增加至 99 美分。这一亏损可能导致更多的流通股，流通股数量已从 2022 年的 1.6 亿增至 1.73 亿。</p>
<p>华尔街分析师对该公司的看法非常悲观，大多数分析师给予持有评级。花旗将其目标价从 10 美元下调至 9 美元，而美国银行则将其目标价从 9 美元下调至 8 美元。</p>
<h2>Teladoc 股价技术分析</h2>
<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2026/01/Teladoc-stock-1024x579.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2026/01/Teladoc-stock-1024x579.png"/></p>
<p>TDOC 股价图表 | 来源：TradingView</p>
<p>日线图显示，Teladoc 的股价在过去几个月中暴跌。从去年 10 月的 9.75 美元跌至目前的 5.74 美元。</p>
<p>进一步观察显示，该股形成了一个头肩顶形态，颈线位于 6.77 美元。左肩位于 9 美元，右肩位于 8 美元。</p>
<p>Teladoc 的股价已跌破所有移动平均线和超级趋势指标。此外，平均方向指数（ADX）已飙升至 20.5，为去年 11 月以来的最高水平。飙升至这一水平是看涨动能持续的迹象。</p>
<p>因此，Teladoc 股价的最可能预测是高度看跌，下一关键支撑位在 5 美元。跌破该价格将预示未来几周可能进一步下跌。</p>
<p>该股的下一个主要催化剂将在 2 月 25 日，公司将发布其财务结果。</p>
<p>本文首发于 Invezz，标题为 “Teladoc 股价创历史新低，风险模式指向更深的下跌”</p>

HEAL

远程医疗和数字健康 ETF - GlobalX

FDHT

TDOC

<p>Teladoc 的股票已跌至历史最低点 5.74 美元，较最高点 308 美元大幅下滑，因疫情后对其远程医疗服务的需求减少。公司的市值已从 460 亿美元骤降至 10 亿美元。第三季度收入下降 2%，为 8.62 亿美元，预计亏损将持续。分析师预测第四季度收入将降至 6.35 亿美元，预计到 2025 年每股年亏损将达到 99 美分。该股票显示出看跌趋势，头肩形态暗示未来可能进一步下跌</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/04/Teladoc.png" alt="" original-src="https://invezz.com/wp-content/uploads/2025/04/Teladoc.png"/></p>
<p>Teladoc stock price crashed to a record low as demand for its services waned after the pandemic. It plunged to a low of $5.74, down sharply from the all-time high of $308, with its market capitalization falling from a high of $46 billion to the current $1 billion. This crash may continue as the stock has formed the bearish head-and-shoulders pattern.</p>
<div class="lb-trans"><p>Teladoc 的股价因疫情后对其服务的需求减弱而暴跌至历史低点，跌至 5.74 美元，较历史最高点 308 美元大幅下跌，市值从 460 亿美元降至目前的 10 亿美元。这一崩盘可能会继续，因为该股形成了看跌的头肩顶形态。</p>
</div><h2>The rapid fall of Teladoc, the biggest player in telehealth</h2>
<div class="lb-trans"><h2>Teladoc 的快速下滑，远程医疗行业的最大参与者</h2>
</div><p>Teladoc, the biggest player in the telehealth industry, has moved from being the hottest company into a fallen angel.</p>
<div class="lb-trans"><p>Teladoc，远程医疗行业的最大参与者，从最受欢迎的公司变成了堕落的天使。</p>
</div><p>This slowdown happened as more patients moved to physical hospitals, leading to a significant slowdown in its business.</p>
<div class="lb-trans"><p>这种放缓发生在更多患者转向实体医院，导致其业务显著放缓。</p>
</div><p>The most recent results showed that its revenue dropped by 2% in the third quarter to $862 million. This slowdown happened even as the healthcare industry continued growing.</p>
<div class="lb-trans"><p>最近的财报显示，其第三季度收入下降了 2%，降至 8.62 亿美元。即使在医疗行业持续增长的情况下，这一放缓依然发生。</p>
</div><p>Its profitability also continued falling, with the adjusted EBITDA moving from $83.3 million in the third quarter of 2024 to $69.9 million.</p>
<div class="lb-trans"><p>其盈利能力也持续下降，调整后的 EBITDA 从 2024 年第三季度的 8330 万美元降至 6990 万美元。</p>
</div><p>Teladoc’s Integrated Care Segment revenue rose from $384 million in Q3’24 to $390 million in Q3’25. However, the BetterHelp segment continued deteriorating, with its sales falling to $237 million from the $257 million in the same period in 2024.</p>
<div class="lb-trans"><p>Teladoc 的综合护理部门收入从 2024 年第三季度的 3.84 亿美元上升至 2025 年第三季度的 3.90 亿美元。然而，BetterHelp 部门持续恶化，其销售额从 2024 年同期的 2.57 亿美元降至 2.37 亿美元。</p>
</div><p>The Integrated Care segment’s EBITDA dropped from $68 million to $66 million, while BetterHelp made just $4 million.</p>
<div class="lb-trans"><p>综合护理部门的 EBITDA 从 6800 万美元降至 6600 万美元，而 BetterHelp 仅赚取了 400 万美元。</p>
</div><p>These numbers happened as the number of users of its two segments diverged. Integrated care users rose to 102.5 million, while BetterHelp shed users to 382,000.</p>
<div class="lb-trans"><p>这些数字的变化与其两个部门用户数量的分化有关。综合护理用户增加至 1.025 亿，而 BetterHelp 用户减少至 38.2 万。</p>
</div><p>Wall Street analysts expect that Teladoc’s business will remain under pressure. The average estimate is that its fourth-quarter revenue will be $635 million, down by 0.81% YoY. If this happens, its annual revenue will be $2.5 billion, down by 1.8% YoY.</p>
<div class="lb-trans"><p>华尔街分析师预计 Teladoc 的业务将继续承压。平均预估其第四季度收入为 6.35 亿美元，同比下降 0.81%。如果这一情况发生，其年收入将为 25 亿美元，同比下降 1.8%。</p>
</div><p>Teladoc’s losses are expected to remain, with the annual loss per share moving to 99 cents in 2025 to 86 cents this year. This loss-making will likely lead to more outstanding shares, which have jumped to 173 million from 160 million in 2022.</p>
<div class="lb-trans"><p>Teladoc 的亏损预计将持续，2025 年的每股年亏损将从今年的 86 美分增加至 99 美分。这一亏损可能导致更多的流通股，流通股数量已从 2022 年的 1.6 亿增至 1.73 亿。</p>
</div><p>Wall Street analysts are highly pessimistic about the company, with most of them having a hold rating. Citigroup reduced its target from $10 to $9, while Bank of America slashed it from $9 to $8.</p>
<div class="lb-trans"><p>华尔街分析师对该公司的看法非常悲观，大多数分析师给予持有评级。花旗将其目标价从 10 美元下调至 9 美元，而美国银行则将其目标价从 9 美元下调至 8 美元。</p>
</div><h2>Teladoc stock price technical analysis</h2>
<div class="lb-trans"><h2>Teladoc 股价技术分析</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2026/01/Teladoc-stock-1024x579.png" alt="" original-src="https://invezz.com/wp-content/uploads/2026/01/Teladoc-stock-1024x579.png"/></p>
<p>TDOC stock chart | Source: TradingView</p>
<div class="lb-trans"><p>TDOC 股价图表 | 来源：TradingView</p>
</div><p>The daily timeframe chart shows that the Teladoc share price has crashed in the past few months. It has crashed from a high of $9.75 in October last year to the current $5.74.</p>
<div class="lb-trans"><p>日线图显示，Teladoc 的股价在过去几个月中暴跌。从去年 10 月的 9.75 美元跌至目前的 5.74 美元。</p>
</div><p>A closer look shows that the stock formed a head-and-shoulders pattern whose neckline was at $6.77. The left shoulder was at $9 and the right one was at $8.</p>
<div class="lb-trans"><p>进一步观察显示，该股形成了一个头肩顶形态，颈线位于 6.77 美元。左肩位于 9 美元，右肩位于 8 美元。</p>
</div><p>Teladoc stock has moved below all moving averages and the Supertrend indicator. Also, the Average Directional Index (ADX) has jumped to 20.5, its highest level since November last year. A surge to this level is a sign that the bullish momentum is continuing.</p>
<div class="lb-trans"><p>Teladoc 的股价已跌破所有移动平均线和超级趋势指标。此外，平均方向指数（ADX）已飙升至 20.5，为去年 11 月以来的最高水平。飙升至这一水平是看涨动能持续的迹象。</p>
</div><p>Therefore, the most likely Teladoc stock price forecast is highly bearish, with the next key support level being at $5. A drop below that price will point to more downside in the coming weeks.</p>
<div class="lb-trans"><p>因此，Teladoc 股价的最可能预测是高度看跌，下一关键支撑位在 5 美元。跌破该价格将预示未来几周可能进一步下跌。</p>
</div><p>The next main catalyst for the stock will be on February 25 when the company publishes its financial results.</p>
<div class="lb-trans"><p>该股的下一个主要催化剂将在 2 月 25 日，公司将发布其财务结果。</p>
</div><p>The post Teladoc hits all-time low as a risky pattern points to a deeper dive appeared first on Invezz</p>
<div class="lb-trans"><p>本文首发于 Invezz，标题为 “Teladoc 股价创历史新低，风险模式指向更深的下跌”</p>
</div>

Teladoc 创下历史新低，因为一种风险模式暗示可能会进一步下跌